Abiopharma

🔍 Wolf Kurt James (Executive)

Company: PITNEY BOWES INC /DE/ (PBI)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Sold 386,480 shares of Common Stock at $18.217 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 2,276,869.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 5,223 shares of Common Stock at $18.962 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 2,271,646.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 38,223 shares of Common Stock at $18.217 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 179,707.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 517 shares of Common Stock at $18.962 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 179,190.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 192,450 shares of Common Stock at $17.53 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 2,079,196.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
• Sold 19,033 shares of Common Stock at $17.53 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 160,157.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
• Sold 376,072 shares of Common Stock at $18.105 per share (Direct)
  Date: 2026-08-03 | Code: S | equity_swap_involved: false | shares_owned_after: 1,703,124.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3
• Sold 37,194 shares of Common Stock at $18.105 per share (Direct)
  Date: 2026-08-03 | Code: S | equity_swap_involved: false | shares_owned_after: 122,963.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-30 | Code: H | shares_owned_after: 1,132,581.00

Footnotes:

• F1: The stock option exercises and broker-assisted sales transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2025 during the Company's open window period (the "Trading Plan").
• F2: The price reported here is a weighted average price. This transaction was executed in multiple transactions at prices ranging from $17.705 to $18.62, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
• F3: The reporting person is the managing member of (a) Hestia Partners GP, the general partner of Hestia Capital Partners, LP (Hestia Capital), and (b) Hestia LLC, the investment manager of Hestia Capital and certain separately managed accounts (the SMAs). As the managing member of each of Hestia Partners GP and Hestia LLC, the reporting person may be deemed the beneficial owner of the shares directly owned by Hestia Capital and shares held in the SMAs. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
• F4: The price reported here is a weighted average price. This transaction was executed in multiple transactions at prices ranging from $18.7408 to $19.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
• F5: The price reported here is a weighted average price. This transaction was executed in multiple transactions at prices ranging from $17.42 to $17.965, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
• F6: The price reported here is a weighted average price. This transaction was executed in multiple transactions at prices ranging from $17.49 to $18.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.